✦ LIBER ✦

Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer

✍ Scribed by Csaba Gajdos; Paul Ian Tartter; Alison Estabrook; Michael A. Gistrak; Shabnam Jaffer; Ira J. Bleiweiss

Publisher: John Wiley and Sons
Year: 2002
Tongue: English
Weight: 137 KB
Volume: 80
Category: Article
ISSN: 0022-4790
DOI: 10.1002/jso.10090

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hormonal receptors in locally advanced b

Hormonal receptors in locally advanced breast cancer: Change with response to neoadjuvant chemotherapy?

✍ Don M. Morris; Jackie Edwards; Frank Gelder 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB

## Abstract Twenty‐one cancers in 20 patients with locally advanced breast cancer were studied. Incisional biopsy was performed without using electrocautery. Tissue was obtained for histology and estrogen (ER) and progesterone (PR) receptors. Patients received chemotherapy after biopsy. All respond

Accuracy of clinical evaluation of local

Accuracy of clinical evaluation of locally advanced breast cancer in patients receiving neoadjuvant chemotherapy

✍ Raquel Prati; Christina A. Minami; Jeff A. Gornbein; Nanette Debruhl; Debbie Chu 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

Management of locally advanced and disse

Management of locally advanced and disseminated breast cancer—chemotherapy

✍ Harry F. Bisel 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 468 KB 👁 2 views

Estrogen receptors and responsiveness of

Estrogen receptors and responsiveness of advanced breast cancer to chemotherapy

✍ Bohumil A. Samal; Samuel C. Brooks; Glen Cummings; Luis Franco; Ervin A. Hire; S 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 278 KB 👁 2 views

We reviewed 89 patients with disseminated breast cancer who had at least one valid estrogen receptor (ER) assay and who underwent one or several trials of chemotherapy. The responses were assessed by two independent extramural reviewers. Of the 89 patients, 81 were evaluable; 28 of 36 (77.8%) ER-pos

Bisphosphonates and pathologic complete

Bisphosphonates and pathologic complete response to taxane- and anthracycline-based neoadjuvant chemotherapy in patients with breast cancer

✍ Mariana Chavez-MacGregor; Erika Brown; Xiudong Lei; Jennifer Litton; Funda Meric 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB 👁 1 views

MRI evaluation of pathologically complet

MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy

✍ Jeon Hor Chen; Byon Feig; Garima Agrawal; Hon Yu; Philip M. Carpenter; Rita S. M 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 325 KB 👁 1 views

## Abstract ## BACKGROUND. This study investigated the role of magnetic resonance imaging (MRI) in evaluation of pathologically complete response and residual tumors in patients who were receiving neoadjuvant chemotherapy (NAC) for both positive and negative HER‐2 breast cancer. ## METHODS. Fift